Fitsum Egziabher-Guebre
Lyon Est
Lyon, 69003, France
Lyon, 69003, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Contrast-enhanced ultrasound and photoacoustic imaging to assess early and late renal ischemia-reperfusion injuries in male mice.
Journal: Physiological reports
Published: April 23, 2026
Renal failure-driven luminal ammonia production impairs gut barrier function in CKD.
Journal: Biochimie
Published: April 15, 2026
Perceived Shared Decision Making during Maintenance Hemodialysis: Associations with Health Literacy, Social Deprivation, and Care Setting.
Journal: Kidney360
Published: January 20, 2026
The Uremic Toxin p-Cresyl Sulfate Is a New Predictor of Major Adverse Cardiovascular Events in Patients with ST-Elevation Myocardial Infarction.
Journal: Toxins
Published: October 28, 2025
Kidney biopsy findings in patients with obesity exhibit a wide spectrum of disease entities.
Journal: Clinical kidney journal
Published: September 11, 2025
Intradialytic parenteral nutrition: theory and practical application
Journal: Nephrologie & therapeutique
Published: May 15, 2025
Concordance of symptoms perceived by patients receiving haemodialysis and those reported by nurses and nephrologists: a cross-sectional, multicentre, observational study using the REIN registry.
Journal: Clinical kidney journal
Published: March 26, 2025
Cold-Inducible RNA-Binding Protein in Cardiac Arrest and Renal Ischemia-Reperfusion Injury: A Translational Approach.
Journal: JACC. Basic to translational science
Published: October 01, 2024
Medium chain fatty acids are potent binding competitors to improve protein-bound uremic toxin clearance during hemodialysis.
Journal: Kidney international
Published: August 20, 2024
The conversational AI "ChatGPT" outperforms medical students on a physiology university examination.
The conversational AI "ChatGPT" outperforms medical students on a physiology university examination.
Journal: Advances in physiology education
Published: July 11, 2024
Efficacy and Safety of Lumasiran for Advanced Primary Hyperoxaluria Type 1: 24-Month Follow-up of the Phase 3 ILLUMINATE-C Trial.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: March 26, 2024
Chronic kidney disease-associated pruritus: a comparison of instruments and associations with patient-reported outcomes using an electronic patient-reported outcome survey in Europe.
Journal: Clinical kidney journal
Published: January 25, 2024
Last Updated: 09/26/2026